Veterinary pharmacy specialty bid moves into public comment

Version 2

Veterinary pharmacy is edging closer to formal specialty recognition, at least on the pharmacy side of the profession. In late February 2026, the Board of Pharmacy Specialties confirmed that it had opened a public comment period on a petition to recognize veterinary pharmacy as a board-certified specialty, marking a notable step for a field that has long argued its work extends well beyond routine dispensing. The petition was submitted in January by the American College of Veterinary Pharmacists, the International College of Veterinary Pharmacists, and the Society of Veterinary Hospital Pharmacists. (pharmacytimes.com)

The idea didn’t appear overnight. BPS had already been studying the field through a veterinary pharmacy job analysis, and ACVP board materials from January 2025 said that analysis was complete and recommendations had been sent to the BPS board for review. That sequence matters because BPS’s own roadmap shows specialty recognition is a staged process: assess the practice area, open public comment on a petition, then decide whether to establish a certification program. Even if approved, the next step would be creation of a specialty council and exam-development work, not immediate certification. (prnewswire.com)

Supporters are framing the proposal around the complexity of animal drug therapy. In the petition summary cited by Pharmacy Times, proponents argue that veterinary pharmacists practice across community and compounding pharmacies, veterinary clinics, teaching hospitals, zoos, aquariums, industry, and government agencies. They describe a role that requires interpreting species-specific clinical data and medication risks that don’t map neatly from human care. ACVP’s public materials make a similar case, saying recognition would standardize training, strengthen collaboration with veterinarians, and affirm pharmacists’ role in animal and public health. That public-health framing is broader than clinic workflow alone: recent discussion in Clinician’s Brief highlighted how uneven access to veterinary care worldwide can affect animal welfare, food security, and zoonotic-disease preparedness, all areas where medication access and appropriate drug use matter. (pharmacytimes.com)

That argument lands in a profession where the need for better veterinary-pharmacy coordination has been visible for years. AVMA policy encourages veterinarians to build strong collegial relationships with pharmacists, and earlier AVMA and NABP policy work pushed for more veterinary pharmacology education in pharmacy curricula and continuing education. At the same time, veterinary pharmacy organizations have continued to build infrastructure around the field, including conferences that offer ACPE-accredited continuing education for pharmacists and RACE-approved education for veterinarians and technicians. The timing also overlaps with a period of rapid therapeutic change. Clinician’s Brief recently noted the fast rise of monoclonal antibodies in veterinary medicine, from dermatology into pain management and other emerging uses, a trend that increases the value of pharmacists who understand species-specific handling, counseling, and formulation issues for newer biologic therapies as well as traditional drugs. (avma.org)

Industry and professional reaction so far has been supportive, at least among the organizations closest to the effort. ACVP called the public comment period “a historic moment” and urged members to submit detailed comments before the April 1, 2026 deadline. Pharmacy Times also characterized the development as a milestone and highlighted the breadth of practice settings named in the petition. I didn’t find independent veterinarian-group statements either endorsing or opposing the proposal yet, which suggests the conversation is still being driven primarily by pharmacy stakeholders rather than by organized veterinary medicine. Still, the issues it touches are familiar to practicing veterinarians: stewardship, client communication, and practical prescribing decisions in busy clinics. Clinician’s Brief recently discussed “wait-and-see” prescriptions in human medicine as one example of how teams are rethinking antibiotic use without worsening outcomes, a reminder that veterinary-pharmacy expertise is relevant not just to dispensing accuracy but also to antimicrobial stewardship and follow-through once a prescription leaves the exam room. (vetmeds.org)

Why it matters: For veterinary teams, this is really a story about medication expertise at a time when prescribing is more distributed than it once was. Companion animal prescriptions now routinely move through retail pharmacies, specialty compounders, and hospital systems that may or may not have deep animal-health experience. A recognized veterinary pharmacy specialty could give DVMs a more reliable way to identify pharmacists with advanced training in species-specific dosing, formulation selection, compounding standards, toxicology, food-animal considerations, regulatory nuances, and emerging therapeutics. That could be especially useful in high-friction areas like compounded preparations, exotic and wildlife species, controlled substances, monoclonal antibody handling and counseling, and client questions that cross from the exam room to the pharmacy counter. (pharmacytimes.com)

There’s also a broader workforce angle. Specialty recognition in pharmacy would not create a new AVMA-recognized veterinary specialty for veterinarians, and it wouldn’t solve shortages in veterinary clinical pharmacology expertise on the DVM side. But it could help formalize a parallel talent pipeline for pharmacists who already support animal care in community practice, teaching hospitals, industry, and public health. That may matter more as the profession wrestles with larger structural pressures, including uneven access to veterinary services and the financial realities facing new graduates. Clinician’s Brief recently highlighted both the global distance many animals face in reaching veterinary care and the long-term weight of veterinary student debt, two different pressures that can shape who enters practice, where they work, and how care gets delivered. For veterinarians, better access to pharmacist support may translate into fewer avoidable medication errors and more practical prescribing backup, especially as more pet parents fill prescriptions outside the clinic. That last point is an inference based on the roles described by ACVP, AVMA’s collaboration guidance, and the long-running policy push for more veterinary pharmacology education in pharmacy practice. (vetmeds.org)

What to watch: The immediate marker is the April 1, 2026 public comment deadline; after that, BPS will decide whether veterinary pharmacy advances to program development, a process that its own guidance suggests can take months and would still require building the certification framework before any credential becomes available. If the proposal moves ahead, the more meaningful test for veterinary medicine will be whether it improves day-to-day support where prescribing complexity is rising fastest: retail pharmacy interfaces, compounded medications, stewardship decisions, and newer drug categories entering general practice. (vetmeds.org)